Telemedicine visits in an established multidisciplinary central nervous system clinic for radiation oncology and neurosurgery (RADIANS) in a community hospital setting.
central nervous system
community hospital
multidisciplinary
neurosurgery
radiation oncology
telemedicine data RADIANS.
Journal
Bratislavske lekarske listy
ISSN: 0006-9248
Titre abrégé: Bratisl Lek Listy
Pays: Slovakia
ID NLM: 0065324
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
31
8
2021
pubmed:
1
9
2021
medline:
7
9
2021
Statut:
ppublish
Résumé
To determine the impact of telemedicine visits, compared to in-person visits, on patient satisfaction in an established community hospital-based multidisciplinary central nervous system (CNS) clinic. Telemedicine options - virtual visits and teleconferencing - were introduced in July 2020. Both radiation oncologist and neurosurgeon were simultaneously present for the telemedicine visit. Descriptive patient demographics, survey responses, and travel time and distance calculations were analyzed. Satisfaction score was compared to previously published data. A total of twenty-five telemedicine visits (n=22 video; n=3 phone) were completed since July 2020. Patient demographics are as follows: mean age was 59 years (range=22-81), women (9) and men (16), repeat telemedicine visits n=10, malignant CNS disease (17) and benign disease (5). Mean one-way distance traveled was 165.07 miles (median=114; range=0.8-358). Mean roundtrip travel time was estimated at 5h 5min. Mean telemedicine visit duration was 15.3 mins (range=4-46). Mean patient satisfaction score for telemedicine visits was 4.84. Patients who opted for the telemedicine visits found them just as effective as in-person visits, saving time and travel costs as well as ensuring patient safety during the current COVID-19 pandemic. The telemedicine visit platform facilitates the multidisciplinary clinic model and should be considered for more widespread utilization (Tab. 3, Fig. 1, Ref. 18).
Identifiants
pubmed: 34463116
doi: 10.4149/BLL_2021_109
pmc: PMC8425713
mid: NIHMS1736831
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
680-683Subventions
Organisme : NINDS NIH HHS
ID : R25 NS108939
Pays : United States
Références
Gen Med Clin Pract. 2021;4(1):
pubmed: 34142091
Nat Rev Clin Oncol. 2020 Jun;17(6):332-334
pubmed: 32341524
Am J Clin Oncol. 2020 Jun;43(6):452-455
pubmed: 32304435
JCO Oncol Pract. 2021 Jan;17(1):e11-e15
pubmed: 33434450
JCO Clin Cancer Inform. 2020 Jul;4:657-665
pubmed: 32716647
World Neurosurg. 2019 Feb;122:8-10
pubmed: 30366142
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
World Neurosurg. 2020 Jul;139:549-557
pubmed: 32426065
Gastroenterology. 2020 Aug;159(2):772-774.e13
pubmed: 32376410
Adv Radiat Oncol. 2020 Mar 27;5(4):538-543
pubmed: 32292841
Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):257-261
pubmed: 32624390
J Natl Med Assoc. 2020 Dec;112(6):563-564
pubmed: 33339569
Pain Physician. 2020 Aug;23(4S):S205-S238
pubmed: 32942812
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810
pubmed: 32238336